Oblique Therapeutics
Oblique Therapeutics AB (publ.) is a Swedish biotech company developing innovative medicines for severe diseases with high unmet medical needs, focusing on pain and advancing a promising internal pipeline.
About Oblique Therapeutics
Oblique Therapeutics is a privately held Swedish biotech company founded in 2015 in Gothenburg, Sweden, focused on developing innovative new medicines for severe diseases with large unmet medical needs particularly in pain management and advanced cancer. The company began its operations in late 2015 and has since pursued advanced therapeutic programs using its proprietary antibody discovery technologies to address challenging biological targets that conventional approaches struggle to treat.
Recently Added Startups
Geowox
Geowox delivers centralised, fast, and data-rich home valuations for mortgage lenders, offering a comprehensive product suite designed to meet complex valuation needs with speed, accuracy, and efficiency.
Bluecode
For banks and retailers around Europe, Bluecode is a mobile payment system that enables quick,
Advisena
Advisena is an AI-Powered Knowledge Consultant that uses your company's data to provide prompt, trustworthy responses.
Related Post
Business Ideas in Czech Republic
Top 10 Semiconductor Manufacturing Companies in Europe 2025
Best Podcast Studios In London – Affordable, Free, And Professional Spaces For Hire
Healthtech
Pilloxa
Pilloxa is a technological, legal, and regulatory platform that enables pharmaceutical and healthcare companies to develop dynamic applications to assist patients.
Hope for Men
Hope for Men is a Berlin-based startup providing a safe, stigma-free space where men can access support, build connections, and find hope, fostering mental well-being and community.
Sweden
BlueCall
BlueCall is a digital platform focused on employee mental health, offering innovative e-health solutions and supporting wellbeing in the workplace as part of the rapidly growing digital health sector.
Oblique Therapeutics
Oblique Therapeutics AB (publ.) is a Swedish biotech company developing innovative medicines for severe diseases with high unmet medical needs, focusing on pain and advancing a promising internal pipeline.